Contributor Page
Norton Rose Fulbright Canada LLP
 
Email  |  Website  |  Articles
Contact Details
Tel: +1 416 2164000
Fax: +1 416 2163930
Suite 3800
Royal Bank Plaza, South Tower
200 Bay Street, P.O. Box 84
Toronto
Ontario M5J 2Z4
Canada
Awards
Contributor Most Read
By Sophie Melchers, Caroline Larouche, Andres Garin
In AMF v. TMF, Baazov, et al. (Court File No. 500-11-052989-171), the Quebec Superior Court confirmed that the Financial Markets Administrative Tribunal has the power to order the Autorité des marchés financiers, ...
By Ahad Ahmed
M&A activity within the cannabis space has continued at a fast pace.
By Chanelle Wong
In Booton v Synergy Plumbing and Heating Ltd., 2019 BCSC 276, an employee successfully sued his former employer for wrongful dismissal as well as defamation in relation to statements made by the employer regarding the reasons for his termination.
By Andréane Giguère
Croyez-vous qu'il est suffisant pour un employeur québécois :
By Mark Convery, Peter Valente
A payments industry that was stagnant and stale for decades has recently entered a transformational and disruptive period of innovation, with seemingly boundless growth ahead.
By Sophie Melchers
In its recent decision (AMF v. Desmarais), the Court of Appeal upheld the conviction of a Montreal lawyer who played a central role in the distribution of investment contracts without a prospectus and who acted as a dealer ...
By Linda Fuerst
In Theroux (Re), 2019 ONSEC 20 a hearing panel of the OSC was called upon to decide whether an individual convicted of five counts of fraud over $5,000 contrary to section 380(1)(a) of the Criminal Code ...
By Troy Ungerman
The Canadian Venture Capital & Private Equity Association (the CVCA) has recently provided insights into Canadian investment trends for the first quarter of 2019 (Q1 2019).
By Denise Gan
The Bill amends the CBCA to comply with this broader interpretation.
By Ian Trimble, Sara Zborovski
Amendments have been proposed to the Food and Drug Regulations that relate to the sale of drugs that have not been approved in Canada for emergency treatment.
By Kassandra Shortt, Christopher Guerreiro, Kristin Wall
CUSMA provides more protections for biologic and innovative pharmaceuticals under Canadian law.
By Linda Fuerst, Peter Choi
On December 31, 2018, the Ontario Superior Court of Justice dismissed an application by Harrington Global Opportunities Fund for a Norwich order against the Investment Industry Regulatory Organization of Canada.
By Peter Choi
Further, the MFDA Hearing Panels imposed over $6M in fines, down from $8.5M in 2017 and $21.1M in 2016.
By Jordana Sanft, Madeleine Hodgson
One of the more substantial changes recommended is the review of safe harbour exceptions for digital intermediaries and internet service providers.
By Daniel Daniele
Online privacy is a fantasy for many people.
Contributor's Topics
More...